Diabetic ketoacidosis induces in vivo activation of human T-lymphocytes

This publication has 18 references indexed in Scilit:

• De novo emergence of growth factor receptors in activated human CD4+ and CD8+ T lymphocytes
  Metabolism, 2004
• Activated T Lymphocytes in Type 2 Diabetes: Implications From in Vitro Studies
  Current Drug Targets, 2003
• Elevated Blood Interleukin-6 Levels in Hyperketonemic Type 1 Diabetic Patients and Secretion by Acetoacetate-Treated Cultured U937 Monocytes
  Diabetes Care, 2003
• Hyperketonemia Increases Tumor Necrosis Factor-α Secretion in Cultured U937 Monocytes and Type 1 Diabetic Patients and Is Apparently Mediated by Oxidative Stress and cAMP Deficiency
  Diabetes, 2002
• Hyperglycemic Crises in Patients With Diabetes Mellitus
  Clinical Diabetes, 2001
• Effect of hyperketonemia on plasma lipid peroxidation levels in diabetic patients.
  Diabetes Care, 1999
• THE CELLULAR AND MOLECULAR MECHANISMS OF DIABETIC COMPLICATIONS
  Endocrinology and Metabolism Clinics of North America, 1996
• Phytohemagglutini (PHA) activated human T-lymphocytes: Concomitant appearance of insulin binding, degradation and insulin-mediated activation of pyruvate dehydrogenase (PDH)
  Biochemical and Biophysical Research Communications, 1986
• Insulin-induced Desensitization at the Receptor and Postreceptor Level in Mitogen-activated Human T-Lymphocytes
  Diabetes, 1985
• Role of insulin in the intermediary metabolism of the activated thymic-derived lymphocyte.
  Journal of Clinical Investigation, 1981